Instrument Inactif

Communiqués Celsus Therapeutics PLC (ADR) Nasdaq

Actions

US15119A2024

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Akari Therapeutics : 2023 Annual Report	05/06	PU
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights	16/05	AQ
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics	01/05	AQ
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity	01/05	AQ
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography Data at ARVO 2024	16/04	AQ
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024	15/04	AQ
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights	01/04	AQ
AKTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Akari Therapeutics, Plc Is Fair to Shareholders	05/03	BU
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit	05/03	AQ
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit	05/03	AQ
Akari Therapeutics Announces Existing Investors Support the Company through a $2 Million Private Placement Financing	03/01	AQ
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing	02/01	AQ
Akari Therapeutics to Present at Biotech Showcase 2024	14/12	AQ
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors	04/12	AQ
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors	01/12	AQ
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy	17/11	AQ
Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference	16/11	AQ
Akari Therapeutics : BioFuture Company Presentation	06/11	PU
Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a Potential Treatment for Geographic Atrophy at the 4th Annual Dry AMD Therapeutic Development Conference	06/11	AQ
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights	02/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Celsus Therapeutics PLC (ADR) Nasdaq

Actions

US15119A2024

Communiqués

Filtres